跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VALCORE TABLET 10MG/10MG - HSA Drug Approval Details
Approvals
/
HSA
/
VALCORE TABLET 10MG/10MG
Approved
THERAPEUTIC
VALCORE TABLET 10MG/10MG
Watson Pharma Private LimitedBalkanpharma-Dupnitsa AD[Primary & Secondary packing]
🇸🇬 Health Sciences Authority
Approval Date
Oct 17, 2017
Approval ID
6c8e18f66ab4828c
Company
Watson Pharma Private LimitedBalkanpharma-Dupnitsa AD[Primary & Secondary packing]
Type
Therapeutic
Approval Details
Approval Id
6c8e18f66ab4828c
Drug Name
VALCORE TABLET 10MG/10MG
Product Name
VALCORE TABLET 10MG/10MG
Approval Number
SIN15346P
Approval Date
2017-10-17
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence Holder
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
C10BA02
Atc Item Name
simvastatin and ezetimibe
Pharma Manufacturer Name
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Company Detail Path
/organization/teva-pharmaceutical-investments-singapore-pte-ltd
Active Ingredients
Ezetimibe
10mg
Simvastatin
10 mg
EZETIMIBE
10 MG
SIMVASTATIN
10 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Oct 17, 2017
Approval ID
6c8e18f66ab4828c
Type
Therapeutic
Back to HSA Approvals